These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 9646097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.
    Torzewski M, Klouche M, Hock J, Messner M, Dorweiler B, Torzewski J, Gabbert HE, Bhakdi S.
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):369-78. PubMed ID: 9514405
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits.
    Schmiedt W, Kinscherf R, Deigner HP, Kamencic H, Nauen O, Kilo J, Oelert H, Metz J, Bhakdi S.
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1790-5. PubMed ID: 9812919
    [Abstract] [Full Text] [Related]

  • 5. Complement and atherogenesis: the unknown connection.
    Bhakdi S.
    Ann Med; 1998 Dec; 30(6):503-7. PubMed ID: 9920350
    [Abstract] [Full Text] [Related]

  • 6. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M, Suriyaphol P, Paprotka K, Spath L, Ochsenhirt V, Schmitt A, Han SR, Husmann M, Gerl VB, Bhakdi S, Lackner KJ.
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
    [Abstract] [Full Text] [Related]

  • 7. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages.
    Klouche M, Gottschling S, Gerl V, Hell W, Husmann M, Dorweiler B, Messner M, Bhakdi S.
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1376-85. PubMed ID: 9743225
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inflammatory reactions in the pathogenesis of atherosclerosis.
    Fan J, Watanabe T.
    J Atheroscler Thromb; 2003 Sep; 10(2):63-71. PubMed ID: 12740479
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of atherosclerosis: infectious versus immune pathogenesis. A new concept.
    Bhakdi S.
    Herz; 2000 Mar; 25(2):84-6. PubMed ID: 10829244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?
    Torzewski M, Lackner KJ.
    Clin Chem Lab Med; 2006 Mar; 44(12):1389-94. PubMed ID: 17163812
    [Abstract] [Full Text] [Related]

  • 15. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S, Torzewski M, Paprotka K, Schmitt S, Barsoom H, Suriyaphol P, Han SR, Lackner KJ, Husmann M.
    Circulation; 2004 Apr 20; 109(15):1870-6. PubMed ID: 15037531
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec 20; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

  • 17. The pathogenesis of atherosclerosis: an overview.
    Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM.
    Clin Cardiol; 1991 Feb 20; 14(2 Suppl 1):I1-16. PubMed ID: 2044253
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
    Ylä-Herttuala S.
    Ann Med; 1991 Feb 20; 23(5):561-7. PubMed ID: 1721825
    [Abstract] [Full Text] [Related]

  • 20. Complement activation by oxidatively modified low-density lipoproteins.
    Wieland E, Dorweiler B, Bonitz U, Lieser S, Walev I, Bhakdi S.
    Eur J Clin Invest; 1999 Oct 20; 29(10):835-41. PubMed ID: 10583425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.